Chennai Meenakshi Multispeciality Hospital (BSE 523489)₹35.11−5.11%Healthcare Service Provider
In the Mar 2026 quarter (standalone), Chennai Meenakshi Multispeciality Hospital reported sales of ₹9.83 Cr, up 6.8% from Mar 2025, and net profit of −₹0.03 Cr, down 109.4% year on year. For the year to Mar 2026, sales were ₹37.13 Cr and net profit −₹1.13 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.09 | 9.54 | 10.10 | 9.58 | 8.77 | 8.09 | 8.86 | 9.20 | 8.67 | 9.50 | 9.14 | 9.83 |
| Expenses | 8.67 | 8.97 | 9.81 | 9.08 | 8.70 | 8.31 | 9.22 | 8.84 | 9.19 | 9.19 | 9.47 | 9.58 |
| Operating Profit | 0.40 | 0.54 | 0.26 | 0.47 | 0.06 | −0.21 | −0.36 | 0.33 | −0.51 | 0.29 | −0.33 | 0.24 |
| OPM % | 4.6% | 5.8% | 2.7% | 5.1% | 0.8% | −2.7% | −4.2% | 3.7% | −6.0% | 3.2% | −3.7% | 2.6% |
| Other Income | 0.11 | 0.05 | 0.16 | 0.19 | 0.09 | 0.09 | 0.27 | 0.43 | 0.28 | 0.35 | 0.28 | 0.25 |
| Interest | 0.24 | 0.24 | 0.24 | 0.25 | 0.25 | 0.24 | 0.24 | 0.23 | 0.23 | 0.24 | 0.23 | 0.24 |
| Depreciation | 0.26 | 0.31 | 0.31 | 0.30 | 0.32 | 0.32 | 0.32 | 0.24 | 0.30 | 0.29 | 0.28 | 0.27 |
| Profit before tax | 0.02 | 0.05 | −0.12 | 0.12 | −0.41 | −0.67 | −0.66 | 0.32 | −0.77 | 0.12 | −0.57 | 0.00 |
| Tax % | 0.0% | 33.4% | −63.6% | 446.3% | −5.0% | −1.5% | −3.1% | 3.3% | −1.3% | −15.3% | −1.8% | — |
| Net Profit | 0.03 | 0.05 | −0.05 | −0.45 | −0.39 | −0.68 | −0.64 | 0.32 | −0.75 | 0.16 | −0.55 | −0.03 |
| EPS (Rs) | 0.04 | 0.06 | −0.06 | −0.60 | −0.52 | −0.91 | −0.85 | 0.43 | −1.00 | 0.21 | −0.73 | −0.04 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.42 | 18.83 | 23.20 | 22.08 | 25.40 | 19.21 | 30.96 | 38.32 | 37.49 | 33.87 | 37.13 | 37.14 |
| Expenses | 17.36 | 17.52 | 19.33 | 19.92 | 22.90 | 18.53 | 25.17 | 35.21 | 35.50 | 34.01 | 37.40 | 37.43 |
| Operating Profit | 3.01 | 1.29 | 3.79 | 2.10 | 2.44 | 0.63 | 5.72 | 3.02 | 1.89 | −0.19 | −0.27 | −0.31 |
| OPM % | 14.9% | 7.0% | 16.5% | 9.7% | 9.7% | 3.4% | 18.7% | 8.0% | 5.1% | −0.6% | −0.8% | −0.8% |
| Other Income | 0.15 | 0.14 | 0.23 | 0.51 | 0.74 | 0.53 | 0.40 | 0.33 | 0.29 | 0.86 | 1.13 | 1.16 |
| Interest | 1.35 | 1.37 | 1.40 | 1.37 | 1.40 | 1.15 | 0.99 | 0.90 | 0.93 | 0.92 | 0.91 | 0.94 |
| Depreciation | 1.17 | 1.13 | 1.16 | 1.21 | 1.25 | 1.28 | 1.16 | 1.17 | 1.17 | 1.17 | 1.10 | 1.14 |
| Profit before tax | 0.67 | −1.06 | 1.50 | 0.06 | 0.54 | −1.24 | 3.97 | 1.29 | 0.09 | −1.43 | −1.16 | −1.22 |
| Tax % | 0.0% | 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 30.5% | 530.1% | −3.5% | −2.6% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.01 | 0.76 | 0.00 | 0.00 | — |
| Net Profit | 0.66 | −1.07 | 1.51 | 0.06 | 0.56 | −1.26 | 3.99 | 0.90 | −0.44 | −1.38 | −1.13 | −1.17 |
| EPS (Rs) | 0.88 | −1.43 | 2.02 | 0.08 | 0.75 | −1.68 | 5.34 | 1.20 | −0.59 | −1.84 | −1.51 | −1.56 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.47 | 7.45 | 7.46 | 7.47 | 7.45 | 7.46 | 7.45 | 7.46 | 7.46 | 7.46 | 7.47 | 7.45 |
| Reserves | −12.95 | −12.31 | −13.22 | −11.65 | −11.62 | −11.05 | −12.26 | −8.27 | −7.36 | −7.82 | −9.37 | −10.56 |
| Borrowings | 12.15 | 12.22 | 12.26 | 12.28 | 12.23 | 11.50 | 11.50 | 10.65 | 10.65 | 11.44 | 10.65 | 10.65 |
| Other Liabilities | 12.11 | 11.15 | 11.89 | 11.31 | 11.17 | 11.59 | 12.55 | 11.60 | 11.41 | 11.78 | 13.82 | 13.75 |
| Total Liabilities | 18.78 | 18.51 | 18.39 | 19.41 | 19.23 | 19.50 | 19.24 | 21.44 | 22.16 | 22.86 | 22.57 | 21.29 |
| Fixed Assets | 15.32 | 14.55 | 14.06 | 14.57 | 14.10 | 13.91 | 12.91 | 14.11 | 13.98 | 14.69 | 13.81 | 12.80 |
| CWIP | 0.02 | 0.06 | 0.01 | 0.03 | 0.11 | 0.11 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 3.44 | 3.90 | 4.32 | 4.81 | 5.02 | 5.48 | 6.22 | 7.33 | 8.18 | 8.17 | 8.76 | 8.49 |
| Inventories | 0.42 | 0.66 | 0.61 | 0.80 | 0.62 | 0.67 | 0.57 | 0.39 | 0.42 | 0.39 | 0.42 | 0.41 |
| Trade receivables | 0.53 | 0.53 | 0.57 | 0.76 | 0.82 | 1.05 | 0.78 | 0.91 | 1.17 | 0.63 | 0.79 | 0.89 |
| Cash & equivalents | 0.75 | 0.85 | 1.65 | 0.90 | 1.00 | 0.92 | 3.09 | 3.25 | 4.54 | 3.80 | 3.41 | 5.25 |
| Total Assets | 18.78 | 18.51 | 18.39 | 19.41 | 19.23 | 19.50 | 19.24 | 21.44 | 22.16 | 22.86 | 22.57 | 21.29 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 3.99 | 1.73 | 2.60 | 2.21 | 2.32 | 2.98 | 3.31 | 3.98 | 2.94 | 2.08 | 2.18 | 0.38 |
| Cash from investing activity | −1.77 | −0.22 | −0.46 | −1.60 | −0.80 | −0.94 | −0.13 | −2.20 | −1.90 | −1.85 | −0.74 | −1.61 |
| Cash from financing activity | −1.99 | −1.40 | −1.31 | −1.36 | −1.40 | −2.11 | −0.97 | −1.61 | −0.74 | 0.02 | −1.55 | −0.73 |
| Net cash flow | 0.21 | 0.09 | 0.81 | −0.76 | 0.09 | −0.07 | 2.17 | 0.13 | 0.28 | 0.25 | −0.13 | −1.99 |
| Capex | 1.56 | 0.47 | 0.57 | 1.70 | 0.89 | 1.09 | 0.29 | 2.42 | 1.10 | 2.22 | 0.28 | 0.11 |
| Free cash flow | 2.44 | 1.27 | 2.06 | 0.55 | 1.43 | 1.96 | 3.01 | 1.67 | 1.88 | 0.02 | 1.91 | 0.26 |
| CFO / OP % | 187.0% | 58.0% | 201.0% | 58.0% | 109.0% | 122.0% | 516.0% | 69.0% | 97.0% | 110.0% | −1,085.0% | −132.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 11 | 10 | 11 | 12 | 14 | 15 | 15 | 11 | 11 | 6 | 9 | 9 |
| Inventory days | 32 | 47 | 46 | 51 | 41 | 39 | 45 | 21 | 23 | 22 | 24 | 20 |
| Days payable | 108 | 80 | 87 | 88 | 80 | 66 | 117 | 106 | 89 | 52 | 89 | 73 |
| Cash conversion cycle | −64 | −23 | −29 | −24 | −25 | −10 | −56 | −73 | −54 | −23 | −55 | −43 |
| Working capital days | −185 | −143 | −178 | −123 | −125 | −95 | −170 | −81 | −66 | −73 | −98 | −90 |
| ROCE % | 14.3% | 28.4% | 4.5% | 39.4% | 17.4% | 24.2% | −1.5% | 59.8% | 21.3% | 11.0% | −5.2% | −3.1% |
For the Mar 2026 quarter, Chennai Meenakshi Multispeciality Hospital reported sales of ₹9.83 Cr, up 6.8% year on year and net profit of −₹0.03 Cr, down 109.4% year on year. The operating margin was 2.6%.
Chennai Meenakshi Multispeciality Hospital's sales for the year to Mar 2026 were ₹37.13 Cr; over the last twelve months they were ₹37.14 Cr.
Net profit for the year to Mar 2026 was −₹1.13 Cr, and −₹1.17 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−1.56.
Chennai Meenakshi Multispeciality Hospital reported borrowings of ₹10.65 Cr at Mar 2026, against cash and equivalents of ₹5.25 Cr.
Cash from operations was ₹0.38 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.26 Cr.